Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

New England Journal of Medicine - Tập 363 Số 14 - Trang 1324-1334 - 2010
Alice L. Yu1,2, Andrew L. Gilman3, M. Fevzi Özkaynak4, Wendy B. London5, Susan G. Kreissman6, Helen X. Chen7, Malcolm A. Smith7, Barry Anderson7, Judith G. Villablanca8, Katherine K. Matthay9, Hiro Shimada8, Stephan A. Grupp10, Robert C. Seeger8, C. Patrick Reynolds11, Allen Buxton12, Ralph A. Reisfeld13, S. D. Gillies14, Susan L. Cohn15, John M. Maris10, Paul M. Sondel16
1Genomics Research Center, Academia Sinica, Taiwan
2University of California, San Diego, and Moores Cancer Center — both in San Diego
3Levine Children's Hospital, Charlotte
4New York Medical College, Valhalla, Dana–Farber Cancer Institute, Children's Hospital Boston
5Children's Oncology Group Statistics and Data Center — all in Boston
6Duke University Medical Center, Durham
7National Cancer Institute, Bethesda, MD
8Children's Hospital Los Angeles, University of Southern California, Los Angeles
9University of California School of Medicine and University of California, San Francisco, Children's Hospital, San Francisco
10Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia
11School of Medicine, Texas Tech University Health Sciences Center, Lubbock
12Children's Oncology Group Statistics and Data Center, Arcadia
13Scripps Research Institute, La Jolla
14Provenance Biopharmaceuticals, Waltham, MA
15University of Chicago, Chicago
16University of Wisconsin Carbone Cancer Center, Madison

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(07)60983-0

10.1056/NEJM199910143411601

10.1200/JCO.2007.13.8925

Schulz G, 1984, Cancer Res, 44, 5914

Cheung NK, 1987, J Clin Oncol, 5, 1430, 10.1200/JCO.1987.5.9.1430

Svennerholm L, 1994, Biochim Biophys Acta, 1214, 115, 10.1016/0005-2760(94)90034-5

10.1016/0022-1759(89)90093-8

Mueller BM, 1990, J Immunol, 144, 1382, 10.4049/jimmunol.144.4.1382

Yu AL, 1998, J Clin Oncol, 16, 2169, 10.1200/JCO.1998.16.6.2169

10.1016/0959-8049(94)00413-Y

Yu AL, 1997, Proc Am Soc Oncol, 6, 1846

Barker E, 1991, Cancer Res, 51, 144

Albertini MR, 1997, Clin Cancer Res, 3, 1277

10.1097/00002371-199909000-00006

Hank JA, 1990, Cancer Res, 50, 5234

10.1200/JCO.2006.10.3564

Ozkaynak MF, 2000, J Clin Oncol, 18, 4077, 10.1200/JCO.2000.18.24.4077

10.2307/2336502

10.2307/2281868

Greenwood M, 1926, Rep Public Health Med Subj (Lond), 33, 1

10.1016/j.ejca.2009.06.010

10.1016/S0304-3959(96)03247-2

10.1016/S0304-3959(96)03280-0

10.1385/MO:18:3:209

Kushner BH, 1992, Blood, 79, 1484, 10.1182/blood.V79.6.1484.1484

Barker E, 1993, Cancer Res, 53, 362

10.4049/jimmunol.0713732

Dallegri F, 1989, Clin Exp Immunol, 77, 58

10.1002/(SICI)1097-0142(19970715)80:2<317::AID-CNCR21>3.0.CO;2-W

10.1158/1078-0432.CCR-03-0799

10.1016/j.coi.2009.03.002

10.1200/JCO.2004.08.143

Simon T, 2009, Pediatr Blood Cancer, 53, 708

10.1200/JCO.2003.05.013

10.1200/JCO.2007.14.8957

10.1007/s00262-008-0613-3

10.1158/1078-0432.CCR-06-1571

10.1007/s10549-008-0251-7

10.1158/1078-0432.CCR-05-2000